Abstract
Conference Article| February 01 1991 Differential regulation of chemoattractant-induced superoxide formation in human neutrophils by cell-permeant analogues of cyclic AMP and cyclic GMP Jürgen Ervens; Jürgen Ervens 1Institut für Pharmakologie, Freie Universität Berlin, Thielallee 69/73, D-1000 Berlin 33, F.R.G. Search for other works by this author on: This Site PubMed Google Scholar Gunter Schultz; Gunter Schultz 1Institut für Pharmakologie, Freie Universität Berlin, Thielallee 69/73, D-1000 Berlin 33, F.R.G. Search for other works by this author on: This Site PubMed Google Scholar Roland Seifert Roland Seifert * *To whom correspondence should be addressed Search for other works by this author on: This Site PubMed Google Scholar Biochem Soc Trans (1991) 19 (1): 59–63. https://doi.org/10.1042/bst0190059 Article history Received: October 10 1990 Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn MailTo Cite Icon Cite Get Permissions Citation Jürgen Ervens, Gunter Schultz, Roland Seifert; Differential regulation of chemoattractant-induced superoxide formation in human neutrophils by cell-permeant analogues of cyclic AMP and cyclic GMP. Biochem Soc Trans 1 February 1991; 19 (1): 59–63. doi: https://doi.org/10.1042/bst0190059 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll JournalsBiochemical Society Transactions Search Advanced Search Keywords: fMet-Leu-Phe, N-formyl-L-methionyl-L-leucyl-L-phenylalanine, Bt2cAMP, N6,2′-O-dibutyryl adenosine 3′:5′-cyclic monosphosphate, Bt2cGMP, N2,2′-O-dibutyryl guanosine 3′:5′-cyclic monophosphate, R-NO, reactive nitrogen oxide, O−2, superoxide anion, G-protein, guanine nucleotide-binding protein This content is only available as a PDF. © 1991 Biochemical Society1991 Article PDF first page preview Close Modal You do not currently have access to this content.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
